Tenet Healthcare Corp. (THC) Stock
Key stats
- Market cap
- $23.32B
- Price / Earnings ratio
- 8.0x
- EPS (TTM)
- $34.70
- Volume
- Loading
- 52-week high
- $301.44
- 52-week low
- $157.58
Source: third-party data provider, as of November 13, 2026
Compare with THC
Recent news

Tenet Healthcare Q3 Earnings Call Highlights
Tenet Healthcare Q3 Earnings Call Highlights
THC

THC Q3 Earnings Call Highlights Higher Outlook and Margin Gains
THC Q3 Earnings Call Highlights Higher Outlook and Margin Gains
THC

THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised
THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised
THC

Tenet (THC) Reports Q3 Earnings: What Key Metrics Have to Say
Tenet (THC) Reports Q3 Earnings: What Key Metrics Have to Say
THC
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 65.65
- MACD 12/26/9
- 6.83
- EMA 9 of MACD
- 4.79
- MACD histogram
- 2.05
- SMA 50
- $266.83
- Price above SMA 50
- EMA 50
- $267.11
- Price above EMA 50
- SMA 200
- $223.86
- Price above SMA 200
- EMA 200
- $231.24
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 8 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $3.95 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Tenet Healthcare Q3 Earnings Call Highlights
Tenet Healthcare Q3 Earnings Call Highlights
THC

THC Q3 Earnings Call Highlights Higher Outlook and Margin Gains
THC Q3 Earnings Call Highlights Higher Outlook and Margin Gains
THC

THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised
THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View Raised
THC

Tenet (THC) Reports Q3 Earnings: What Key Metrics Have to Say
Tenet (THC) Reports Q3 Earnings: What Key Metrics Have to Say
THC

Tenet Healthcare (THC) Surpasses Q3 Earnings and Revenue Estimates
Tenet Healthcare (THC) Surpasses Q3 Earnings and Revenue Estimates
THC

Tenet Reports Strong Third Quarter 2026 Results; Raises 2026 Financial Outlook
Tenet Reports Strong Third Quarter 2026 Results; Raises 2026 Financial Outlook
THC

Here's Why Tenet Healthcare (THC) is a Strong Value Stock
Here's Why Tenet Healthcare (THC) is a Strong Value Stock
THC

Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength?
Can Tenet Healthcare Beat Q3 Earnings on Ambulatory Care Strength?
THC

Here's Why Tenet Healthcare (THC) is a Strong Momentum Stock
Here's Why Tenet Healthcare (THC) is a Strong Momentum Stock
THC

Insights Into Tenet (THC) Q3: Wall Street Projections for Key Metrics
Insights Into Tenet (THC) Q3: Wall Street Projections for Key Metrics
THC
News tone: automated (AI) classification of the article's content, not a price prediction.
About Tenet Healthcare Corp.
Tenet Healthcare is a Dallas-based healthcare services organization. It operates acute and specialty hospitals (47 as of December 2024) and over 500 ambulatory surgery centers and other outpatient facilities across the US, primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Dr. Saumya Sutaria M.D. | Chairman & CEO | 1973 |
| Mr. Sun K. Park | Executive VP & CFO | 1976 |
| Ms. Lisa Y. Foo | Executive VP & Chief Operating Officer | 1991 |
| Ms. Paola M. Arbour | Executive VP & Chief Information Officer | 1964 |
| Mr. Thomas W. Arnst | EVP, Chief Administrative Officer, Chief Risk Officer, General Counsel & Corporate Secretary | 1963 |
| Mr. John Michael Grooms | Senior VP, Controller & Principal Accounting Officer | 1978 |
| Mr. William McDowell III | Vice President of Investor Relations | — |
| Ms. Jana Durfee | Senior VP & Chief Compliance Officer | — |
| Mr. Michael T. Maloney | Executive Vice President of Corporate Development | — |
| Mr. Clint Hailey | Chief Managed Care Officer & Senior VP | 1965 |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of November 13, 2026
Technical indicators
- RSI 14
- 65.65
- MACD 12/26/9
- 6.83
- EMA 9 of MACD
- 4.79
- MACD histogram
- 2.05
- SMA 50
- $266.83
- Price above SMA 50
- EMA 50
- $267.11
- Price above EMA 50
- SMA 200
- $223.86
- Price above SMA 200
- EMA 200
- $231.24
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of November 11, 2026. Technical data, not a recommendation.
Analyst views
8 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $265.00
- Average
- $305.00
- High
- $342.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -9.2 | +15.8 | ||||||||||
| 2022 | -7.3 | +15.2 | -2.4 | -16.4 | -9.8 | -16.7 | +20.2 | -13.9 | -8.5 | -17.3 | +1.2 | +7.6 |
| 2023 | +12.0 | +3.1 | -0.2 | +25.5 | -1.5 | +12.2 | -8.1 | +1.0 | -16.3 | -18.8 | +30.0 | +6.4 |
| 2024 | +8.8 | +4.4 | +11.5 | +7.6 | +16.6 | -0.5 | +12.3 | +12.1 | +2.8 | -4.8 | -8.6 | -11.1 |
| 2025 | +12.5 | -12.5 | +8.0 | +7.2 | +16.2 | +3.5 | -9.1 | +16.6 | +9.5 | +2.6 | +7.7 | -7.6 |
| 2026 | -5.1 | +27.3 | -19.7 | -6.9 | -4.3 | +10.0 | +33.3 | +6.4 | -3.9 | +7.6 | +9.0 |



